Preoperative intensity-modulated chemoradiation therapy with simultaneous integrated boost in rectal cancer: 2-year follow-up results of phase II study
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Bujko K, Michalski W Kepka L, Nowacki MP Nasierowska-Guttmejer A, Tokar P et al. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: an analysis of outcomes in a randomized trial. Int J Radiat Oncol Biol Phys 2007; 67: 369-77. 10.1016/j.ijrobp.2006.08.065BujkoKMichalskiWKepkaLNowackiMPNasierowska-GuttmejerATokarPAssociation between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: an analysis of outcomes in a randomized trialInt J Radiat Oncol Biol Phys2007673697710.1016/j.ijrobp.2006.08.065Open DOISearch in Google Scholar
Leibold T, Shia J, Ruo L, Minsky BD, Akhurst T, Gollub M J, et al. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. J Clin Oncol 2008; 26: 2106-11. 10.1200/JC0.2007.12.770418362367LeiboldTShiaJRuoLMinskyBDAkhurstTGollubM JPrognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapyJ Clin Oncol20082621061110.1200/JC0.2007.12.7704Open DOISearch in Google Scholar
Gérard JP, Azria D, Gourgou-Bourgade S, Martel-Lafay I, Hennequin C, Etienne PL, et al. Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. J Clin Oncol 2012; 30: 4558-65. 10.1200/JCO.2012.42.877123109696GérardJPAzriaDGourgou-BourgadeSMartel-LafayIHennequinCEtiennePLClinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancerJ Clin Oncol20123045586510.1200/JCO.2012.42.8771Open DOISearch in Google Scholar
Rödel C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol 2012; 13: 679-87. 10.1016/S1470-2045(12)70187-022627104RödelCLierschTBeckerHFietkauRHohenbergerWHothornTPreoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trialLancet Oncol2012136798710.1016/S1470-2045(12)70187-0Open DOISearch in Google Scholar
Velenik V, Ocvirk J, Music, M, Bracko M, Anderluh F, Oblak I, et al. Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study. Radiat Oncol. 2011; 6: 105. 10.1186/1748-717X-6-10521880132VelenikVOcvirkJMusicMBrackoMAnderluhFOblakINeoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II studyRadiat Oncol.2011610510.1186/1748-717X-6-105317972021880132Open DOISearch in Google Scholar
Arbea L, Ramos, LI, Martínez-Monge R, Moreno M, Aristu, J. Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications, Radiat Oncol 2010; 5: 17. 10.1186/1748-717X-5-1720187944ArbeaLRamosLIMartínez-MongeRMorenoMAristuJ.Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implicationsRadiat Oncol201051710.1186/1748-717X-5-17284559320187944Open DOISearch in Google Scholar
Guerrero Urbano MT, Henrys AJ, Adams EJ, Norman AR, Bedford JL, Harrington KJ, et al. Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int J Radiat Oncol Biol Phys 2006; 65: 907-16. 10.1016/j.ijrobp.2005.12.05616751073Guerrero UrbanoMTHenrysAJAdamsEJNormanARBedfordJLHarringtonKJIntensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levelsInt J Radiat Oncol Biol Phys2006659071610.1016/j.ijrobp.2005.12.05616751073Open DOISearch in Google Scholar
Engels B, De Ridder M, Tournel K, Sermeus A, De Coninck P, Verellen D, et al. Preoperative helical tomotherapy and megavoltage computed tomography for rectal cancer: impact on the irradiated volume of small bowel. Int J Radiat Oncol Biol Phys 2009; 74: 1476-80. 10.1016/j.ijrobp.2008.10.01719231097EngelsBDe RidderMTournelKSermeusADe ConinckPVerellenDPreoperative helical tomotherapy and megavoltage computed tomography for rectal cancer: impact on the irradiated volume of small bowelInt J Radiat Oncol Biol Phys20097414768010.1016/j.ijrobp.2008.10.01719231097Open DOISearch in Google Scholar
Mok H, Crane CH, Palmer MB, Briere TM, Beddar S, Delclos ME, et al. Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma. Radiat Oncol 2011; 6: 63. 10.1186/1748-717X-6-6321651775MokHCraneCHPalmerMBBriereTMBeddarSDelclosMEIntensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinomaRadiat Oncol201166310.1186/1748-717X-6-63312160621651775Open DOISearch in Google Scholar
Li JL, Ji JF, Cai Y, Li XF, Li YH, Wu H, et al. Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial”. Radiother Oncol 2012; 102: 4-9. 10.1016/j.radonc.2011.07.03021903285LiJLJiJFCaiYLiXFLiYHWuHPreoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial”Radiother Oncol20121024910.1016/j.radonc.2011.07.03021903285Open DOISearch in Google Scholar
Engels B, Platteaux N, Van den Begin R, Gevaert T, Sermeus A, Storme, G, et al. Preoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: report on late toxicity and outcome. Radiother Oncol 2014; 110: 155-9. 10.1016/j.radonc.2013.10.02624239243EngelsBPlatteauxNVan den BeginRGevaertTSermeusAStormeGPreoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: report on late toxicity and outcomeRadiother Oncol2014110155910.1016/j.radonc.2013.10.02624239243Open DOISearch in Google Scholar
Hernando-Requejo O, López M, Cubillo A, Rodriguez A, Ciervide R, Valero J, et al. Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation. Strahlenther Onkol 2014;190: 515-20. 10.1007/s00066-014-0650-024715243Hernando-RequejoOLópezMCubilloARodriguezACiervideRValeroJComplete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiationStrahlenther Onkol20141905152010.1007/s00066-014-0650-024715243Open DOISearch in Google Scholar
Picardi V, Macchia G, Guido A, Giaccherini L, Deodato F, Farioli A, et al. Preoperative chemoradiation with VMAT-SIB in rectal cancer: a phase II study. Clin Colorectal Cancer 2016. 10.1016/j.clcc.2016.06.004PicardiVMacchiaGGuidoAGiaccheriniLDeodatoFFarioliAPreoperative chemoradiation with VMAT-SIB in rectal cancer: a phase II studyClin Colorectal Cancer 201610.1016/j.clcc.2016.06.00427435759Open DOISearch in Google Scholar
Hong TS, Moughan J, Garofalo MC, Bendell J, Berger AC, Oldenburg NBE, et al. NRG Oncology Radiation Therapy Oncology Group 0822: a phase 2 study of preoperative chemoradiation therapy using intensity modulated radiation therapy in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2015; 93: 29-36. 10.1016/j.ijrobp.2015.05.00526163334HongTSMoughanJGarofaloMCBendellJBergerACOldenburgNBENRG Oncology Radiation Therapy Oncology Group 0822: a phase 2 study of preoperative chemoradiation therapy using intensity modulated radiation therapy in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancerInt J Radiat Oncol Biol Phys201593293610.1016/j.ijrobp.2015.05.005454062826163334Open DOISearch in Google Scholar
Zhu J, Liu F, Gu W, Lian P, Sheng W, Xu J, et al. “Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study. Radiat Oncol 2014; 9: 70. 10.1186/1748-717X-9-7024606870ZhuJLiuFGuWLianPShengWXuJ“Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II studyRadiat Oncol201497010.1186/1748-717X-9-70398473324606870Open DOISearch in Google Scholar
But-Hadzic J, Anderluh F, Brecelj E, Edhemovic I, Secerov-Ermenc A, Hudej R, et al. Acute toxicity and tumor response in locally advanced rectal cancer after preoperative chemoradiation therapy with shortening of the overall treatment time using intensity-modulated radiation therapy with simultaneous integrated boost: a phase 2 trial. Int J Radiat Oncol Biol Phys 2016; 96: 1003-10. 10.1016/j.ijrobp.2016.08.03127727065But-HadzicJAnderluhFBreceljEEdhemovicISecerov-ErmencAHudejRAcute toxicity and tumor response in locally advanced rectal cancer after preoperative chemoradiation therapy with shortening of the overall treatment time using intensity-modulated radiation therapy with simultaneous integrated boost: a phase 2 trialInt J Radiat Oncol Biol Phys20169610031010.1016/j.ijrobp.2016.08.03127727065Open DOISearch in Google Scholar
ICRU. Prescribing, recording and reporting photon beam therapy (ICRU report 50). ICRU Report 1993: 357-60. 10.2307/3578862ICRU. Prescribing, recording and reporting photon beam therapy (ICRU report 50)ICRU Report19933576010.2307/3578862Open DOISearch in Google Scholar
Gregoire V, Mackie TR. Dose prescription, reporting and recording in intensity-modulated radiation therapy: a digest of the ICRU Report 83. Imaging Med 2011; 3: 367-73. 10.2217/iim.11.22GregoireVMackieTR.Dose prescription, reporting and recording in intensity-modulated radiation therapy: a digest of the ICRU Report 83Imaging Med201133677310.2217/iim.11.22Open DOISearch in Google Scholar
Van Triest B, Nijkamp J, van Herk M, Sonke JJ, de Jong R, Hollmann B, et al. Repeat CT assessed CTV variation and PTV margins for short- and long-course pre-operative RT of rectal cancer. Radiother Oncol 2012; 102: 399-405. 10.1016/j.radonc.2011.11.011Van TriestBNijkampJvan HerkMSonkeJJde JongRHollmannBRepeat CT assessed CTV variation and PTV margins for short- and long-course pre-operative RT of rectal cancerRadiother Oncol201210239940510.1016/j.radonc.2011.11.01122239865Open DOISearch in Google Scholar
Glimelius B, Gronberg H, Jarhult J, Wallgren A, Cavallin-Stahl E, Grönberg H, et al. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003; 42: 476-92.10.1080/0284186031001230114596508GlimeliusBGronbergHJarhultJWallgrenACavallin-StahlEGrönbergHA systematic overview of radiation therapy effects in rectal cancerActa Oncol2003424769214596508Open DOISearch in Google Scholar
U. S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common terminology criteria for adverse events (CTCAE), Version 4.0 (CTCAE). May 28, 2009: Available at: https://www.eortc.be/services/doc/ctc/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. [Citated 2017 Jun 15].U. S. Department of Health and Human Services, National Institutes of Health, National Cancer InstituteCommon terminology criteria for adverse events (CTCAE), Version 4.0 (CTCAE)May 282009https://www.eortc.be/services/doc/ctc/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf[Citated 2017 Jun 15]Search in Google Scholar
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471–4. 10.1245/s10434-010-0985-420180029EdgeSBComptonCC.The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNMAnn Surg Oncol2010171471410.1245/s10434-010-0985-4Open DOISearch in Google Scholar
Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997; 12: 19-23.911214510.1007/s003840050072DworakOKeilholzLHoffmannA.Pathological features of rectal cancer after preoperative radiochemotherapyInt J Colorectal Dis1997121923Search in Google Scholar
Velenik V, Oblak I, Anderluh F. Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer. Radiat Oncol 2010; 5: 88. 10.1186/1748-717X-5-8820920276VelenikVOblakIAnderluhF.Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancerRadiat Oncol201058810.1186/1748-717X-5-88Open DOISearch in Google Scholar
Burbach JPM, den Harder AM, Intven M, van Vulpen M, Verkooijen HM, Reerink O. Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysis. Radiother Oncol 2014; 113: 1-9. 10.1016/j.radonc.2014.08.03525281582BurbachJPMden HarderAMIntvenMvan VulpenMVerkooijenHMReerinkO.Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysisRadiother Oncol20141131910.1016/j.radonc.2014.08.035Open DOISearch in Google Scholar
Suwinski R, Taylor JM, Withers HR. Rapid growth of microscopic rectal cancer as a determinant of response to preoperative radiation therapy. Int J Radiat Oncol Biol Phys 1998; 42: 943-51. http://dx.doi.org/10.1016/S0360-3016(98)00343-510.1016/S0360-3016(98)00343-59869214SuwinskiRTaylorJMWithersHR.Rapid growth of microscopic rectal cancer as a determinant of response to preoperative radiation therapyInt J Radiat Oncol Biol Phys19984294351http://dx.doi.org/10.1016/S0360-3016(98)00343-5Open DOISearch in Google Scholar
Fokas E, Liersch T, Fietkau R, Hohenberger W, Beissbarth T, Hess C, et al. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial. J Clin Oncol 2014; 32: 1554-62. 10.1200/JCO.2013.54.3769FokasELierschTFietkauRHohenbergerWBeissbarthTHessCTumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trialJ Clin Oncol20143215546210.1200/JCO.2013.54.376924752056Open DOISearch in Google Scholar
Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2003; 227: 371-7. 10.1148/radiol.227201174712732695BrownGRichardsCJBourneMWNewcombeRGRadcliffeAGDallimoreNSMorphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparisonRadiology2003227371710.1148/radiol.227201174712732695Open DOISearch in Google Scholar
Lobefalo F, Bignardi M, Reggiori G, Tozzi A, Tomatis S, Alongi F, et al. Dosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition case. Radiat Oncol 2013; 8: 176. 10.1186/1748-717X-8-17623837942LobefaloFBignardiMReggioriGTozziATomatisSAlongiFDosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition caseRadiat Oncol2013817610.1186/1748-717X-8-176372025423837942Open DOISearch in Google Scholar
O’Neill BD, Salerno G, Thomas K, Tait DM, Brown G. MR vs CT imaging: low rectal cancer tumour delineation for three-dimensional conformal radiotherapy. Br J Radiol 2009; 82: 509-13. 10.1259/bjr/6019887319153180O’NeillBDSalernoGThomasKTaitDMBrownG.MR vs CT imaging: low rectal cancer tumour delineation for three-dimensional conformal radiotherapyBr J Radiol2009825091310.1259/bjr/6019887319153180Open DOISearch in Google Scholar
Glynne-Jones R, Mawdsley S, Pearce T, Buyse M. Alternative clinical end points in rectal cancer - are we getting closer? Ann Oncol 2006; 17: 1239-48. 10.1093/annonc/mdl17316873440Glynne-JonesRMawdsleySPearceTBuyseM.Alternative clinical end points in rectal cancer - are we getting closer?Ann Oncol20061712394810.1093/annonc/mdl17316873440Open DOISearch in Google Scholar
Rödel C, Martus P, Papadoupolos T, Füzesi L, Klimpfinger M, Fietkau R, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005; 23: 8688-96. 10.1200/JCO.2005.02.132916246976RödelCMartusPPapadoupolosTFüzesiLKlimpfingerMFietkauRPrognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancerJ Clin Oncol20052386889610.1200/JCO.2005.02.132916246976Open DOISearch in Google Scholar
